Serelaxin

Serelaxin is a prescription medication used to treat acute heart failure (AHF). It is a recombinant form of human relaxin-2, a naturally occurring hormone in the body that helps to regulate blood pressure and other cardiovascular functions. Serelaxin works by activating the receptor for relaxin-2, which helps to reduce the symptoms of AHF. It is typically taken as an intravenous infusion over a period of 48 hours. Common side effects include headache, nausea, and dizziness.

Serelaxin is a medication that's currently only marketed in Russia for the treatment of a specific heart condition: acute heart failure (AHF). Here's a closer look at what it is and how it works:

Origin and Function:

• Recombinant human relaxin-2: Serelaxin is an engineered version (recombinant) of a naturally occurring hormone called relaxin-2, produced during pregnancy.
• Vasodilation and beyond: Relaxin-2 helps with cardiovascular and kidney adaptations during pregnancy. Serelaxin acts similarly, causing blood vessel widening (vasodilation) to improve blood flow and potentially offering other benefits like reducing inflammation and protecting heart tissue.

Development and Usage:

• Limited availability: While studied for use in other regions like the US and Europe, Serelaxin is not currently marketed there. In Russia, it's sold under the brand name Reasanz.

Important Points to Consider:

• How it's given: Serelaxin is typically administered intravenously (through a vein).
• Research status: Clinical trials to assess its effectiveness in other parts of the world are ongoing, but more research is needed for definitive conclusions.
• Not a first-line treatment: If you have AHF, Serelaxin would likely be considered alongside other standard medications for this condition.
• Limited information on side effects: As its use is concentrated in Russia, detailed information on side effects might be limited in English sources.